Learn how to build decision-grade disease registries that turn real-world data into reliable evidence for regulatory, clinical, and market-access decisions.
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Managing Drug And Data Requirements In Decentralized Clinical Trials
Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies
Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials
We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing.
-
Implementing eSource: A Guide For Operations And Technology Roles
By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.
-
C3 Summit Recap: Shaping The Future Of eCOA/ePRO Highlights
Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.
-
Building A Gold Standard Trial Experience In Japan
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
Benefits Of Using ePRO In Early Phase Studies
Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.
-
Advancing Electronic Clinical Outcome Assessments
Learn how to streamline the collection of essential data, thus alleviating patient burdens, all the while upholding data integrity within a flexible trial environment.
-
Are You Aiming For The Bullseye Or Just The Target?
Learn what this author has to say about focusing on a clinical trial's outcome when developing Risk-Based Quality Management strategies.
RECENT NEWSLETTERS
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps